<DOC>
	<DOCNO>NCT01619072</DOCNO>
	<brief_summary>This randomize control community-based trial ass effectiveness administration 800 mcg sublingual misoprostol standard care vs. placebo standard care postpartum hemorrhage treatment community level , primarily home birth attend primary health care unit ( PHU ) staff Etay El Barood Kafr El Dawar district ( El Beheira governorate ) , Egypt . Standard care per national guideline set referral high level health facility .</brief_summary>
	<brief_title>Misoprostol Treatment Postpartum Hemorrhage Community-level Births Egypt</brief_title>
	<detailed_description>Hospital-based clinical trial demonstrate misoprostol safe effective treatment option postpartum hemorrhage ( PPH ) . Additional research need demonstrate finding translate program effectiveness low level health care system , include community home birth , access skilled provider treatment option limit misoprostol could potentially greatest impact maternal health outcome . This randomize control community treatment trial ass effectiveness misoprostol standard care ( i.e. , referral high level care ) vs. placebo standard care PPH treatment community level , primarily home birth attend primary health care unit staff Etay El Barood Kafr El Dawar district ( El Beheira governorate ) , Egypt . This research help guide decision introduce misoprostol PPH care program different contexts primary care setting , include community-based home birth .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>woman deliver provider participate primary health unit ( PHU ) willing able give inform consent vaginal delivery woman advance active labor provide inform consent know allergy misoprostol and/or prostaglandin woman present pregnancy complication , hypertension , suspect multiple pregnancy , previous caesarean section , suspect still birth , antepartum hemorrhage , previous complication third trimester ( refer high level care delivery )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>postpartum hemorrhage</keyword>
	<keyword>treatment</keyword>
	<keyword>misoprostol</keyword>
	<keyword>home birth</keyword>
</DOC>